Effective Phaco Time and Endothelial Cell Loss When Using Veritas
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Veritas Vision System.
- Who it may be relevant to
- Registry conditions: Cataract. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Assessment of Effective Phaco Time and Endothelial Cell Loss When Using a Novel Dual Mode Phacoemulsification System
Overview
This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.
Interventions
- Device Veritas Vision System
Veritas Vision System
Primary outcome measures
- Effective phaco time per phacoemulsification procedure [Time frame: Surgery (Day 0)]
Secondary outcome measures (4)
- Endothelial cell loss [Time frame: 1 monthspostoperatively]
- Total case time [Time frame: Surgery (Day 0)]
- Total phaco time [Time frame: Surgery (Day 0)]
- Total volume used [Time frame: Surgery (Day 0)]
Eligibility criteria
Inclusion criteria
- Adult patients undergoing age-related cataract surgery.
- Planned use of the Catalys Precision Laser System.
- Planned implantation of TECNIS intraocular lenses (IOLs).
Exclusion criteria
- Moderate-severe any disease state (deemed by the surgeon) that could increase risk of complicated cataract surgery (ie, pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, and prior refractive surgery).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Aloha Vision Consultants — ‘Aiea
Identifiers
NCT: NCT07176416 · CY-25-01